TWO SIGMA ADVISERS, LP - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$41,790
+48.1%
19,900
-3.4%
0.00%
Q4 2022$28,222
+8.5%
20,600
-18.6%
0.00%
Q3 2022$26,000
-67.5%
25,300
-65.7%
0.00%
Q2 2022$80,000
+29.0%
73,671
+25.1%
0.00%
Q1 2022$62,000
-25.3%
58,900
-41.0%
0.00%
Q4 2021$83,000
+336.8%
99,900
+603.5%
0.00%
Q3 2021$19,00014,2000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Spire Wealth Management 148,800$158,0000.00%
MEITAV INVESTMENT HOUSE LTD 244,332$257,0000.00%
Phoenix Holdings Ltd. 244,113$259,0000.00%
IHT Wealth Management, LLC 24,000$25,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Virtu Financial LLC 15,199$16,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 41,574$44,0000.00%
Smith Salley Wealth Management 12,048$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 28,790$31,0000.00%
BANK OF AMERICA CORP /DE/ 5,153$5,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders